Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait

Table 4 Distribution of A. flavus isolates according to MIC values

		Cumulative % of isolates inhibited at MIC of
Antifungal agent	Medium	≤ 0.002	≤ 0.004	≤ 0.008	≤ 0.016	≤ 0.032	≤ 0.064	≤ 0.128	≤ 0.256	≤ 0.512	≤ 1.024	≤ 2.048	≤ 4.096	≤ 8.192
Amphotericin B	RPMI						1.07	2.1	5.4	45.2	74.2	89.2	100
Amphotericin B	MH-GMB							3.2	4.3	36.6	59.1	81.7	96.8	100
Voriconazole	RPMI						3.2	67.7	100
Voriconazole	MH-GMB						4.3	77.4	100
Posaconazole	RPMI			1.07	3.2	17.2	47.3	78.5	100
Posaconazole	MH-GMB			1.07	2.1	9.7	37.6	70.9	93.5	100
Anidulafungin	RPMI	96.8	98.9	100
Anidulafungin	MH-GMB	89.2	93.5	98.9	100
Micafungin	RPMI	95.7	96.8	100
Micafungin	MH-GMB	94.6	96.8	100
Caspofungin	RPMI	5.4		63.4	87.1	97.8	98.9	100
Caspofungin	MH-GMB	1.07	2.1	33.3	79.6	98.9		100

ISSN: 1471-2334